Exciva GmbH develops a groundbreaking therapy that effectively and safely addresses neuropsychiatric symptoms of dementia including agitation/aggression in Alzheimer’s disease dementia. They aim to improve the quality of life and independence of patients, reduce distress for caregivers and support patients' families.